BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

Monday’s Trading Day
8.57 +0.27 / +3.25%
As of Mar 30
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
9.21 +0.64 / +7.47%
Volume: 16.1K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues19.6M26.3M17.3M13.6M
Cost of Goods Sold0.00132.0K98.0K122.0K
Depreciation And Amortization886.0K628.0K304.0K177.0K
Operating ExpensesGross Income18.8M25.5M16.9M13.3M
General Expenses68.3M56.2M42.6M59.1M
Research And Development56.9M51.5M37.7M51.8M
Total Operating Expenses69.2M56.9M43.0M59.4M
Non-Operating ExpensesOperating Income-49.6M-30.6M-25.7M-45.8M
Extraordinary Credit0.000.005.3M5.5M
Extraordinary Charge-4.0M-4.0M-5.0M--
Interest Expense On Debt3.8M4.7M4.8M5.0M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-56.9M-39.1M-30.1M-45.2M
Net Income-56.9M-39.1M-30.1M-45.2M
Shares To Calculate EPSShares To Calculate EPS45.1M49.5M55.2M66.8M
Shares To Calculate EPS Diluted45.1M49.5M55.2M66.8M
Earnings Per ShareEPS-$1.26-$0.79-$0.55-$0.68
EPS Diluted-$1.26-$0.79-$0.55-$0.68

To view my watchlist

Not a member yet?

Sign up now for a free account